VIDD scientists and affiliates study all of the human herpesviruses (CMV, EBV, HHV-6, HHV-8, HSV-1, HSV-2 and VZV) with the collective aim of understanding how to mitigate viral infection outcomes. Herpesvirus infections such as CMV are of special concern in the immunocompromised patient population where they can cause severe morbidity and in some cases promote the development of certain human cancers. Our internationally renowned researchers are exploring novel and diverse approaches to reduce the impact of these viruses on patients. VIDD, with UW partners, has a world renowned program to study the natural history and host-pathogen interactions in genital herpes and neonatal herpes. VIDD scientists have conducted pioneering research to identify prevention and therapeutic strategies and have developed novel techniques to diagnose infections in infants and adults.